Medical ProductsCompany
CorMatrix Cardiovascular - Synthetic Royalty and Milestone Rights Ownership
Who owns CorMatrix Cardiovascular - Synthetic Royalty and Milestone Rights?
CorMatrix Cardiovascular - Synthetic Royalty and Milestone Rights is owned by Ligand Pharmaceuticals. It was acquired on May 4, 2016.
CorMatrix Cardiovascular - Synthetic Royalty and Milestone Rights Business Overview
Where is CorMatrix Cardiovascular - Synthetic Royalty and Milestone Rights headquartered?
CorMatrix Cardiovascular - Synthetic Royalty and Milestone Rights is headquartered in United States.
What sector is CorMatrix Cardiovascular - Synthetic Royalty and Milestone Rights in?
CorMatrix Cardiovascular - Synthetic Royalty and Milestone Rights is a medical products company.
Medical Products M&A Summary in 2016
Out of 60 sectors in the Mergr database, medical products ranked 10 in number of deals in 2016. The largest medical products acquisition in 2016 was St. Jude Medical - which was acquired by Abbott Laboratories for $25.0B.
Join Mergr to view all 273 acquisitions of medical products companies in 2016, including 32 acquisitions by private equity firms, and 241 by strategics.